Dr. Artz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Leukemia
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-389-3060- Is this information wrong?
Summary
- Dr. Andrew Artz is a hematologist/oncologist affiliated with City of Hope Medical Center in Duarte, CA. He received his medical degree from West Virginia University School of Medicine, medicine training at Georgetown University, and Hematology/Oncology fellowship at the University of Chicago. He specializes in treating blood cancers through the use of stem cell transplantation. Dr. Artz is the Director of the Program for Aging and Blood Cancers at City of Hope.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1997 - 2000
- West Virginia University School of MedicineClass of 1997
Certifications & Licensure
- IL State Medical License 2000 - 2026
- CA State Medical License 2019 - 2025
- VA State Medical License 1998 - 2002
- DC State Medical License 1999 - 2002
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies Start of enrollment: 2001 Nov 01
- Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes Start of enrollment: 2008 Oct 02
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.Nina Rosa Neuendorff, Abdullah Khan, Fabian Ullrich, Samuel Yates, Srinivas Devarakonda, Richard J Lin, Bastian von Tresckow, Raul Cordoba, Andrew Artz, Ashley E Rosko> ;Journal of Geriatric Oncology. 2024 Apr 1
- Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly.Justin J Yoo, Harvey J Cohen, Andrew S Artz, Elizabeth Price, Jeffrey A Fill, Josef Prchal, Shelly Sapp, Huiman Barnhart> ;Hematology. 2023 Dec 1
- 2 citationsEfficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.Karol M Pencina, Thomas G Travison, Andrew S Artz, A Michael Lincoff, Steven E Nissen, Panagiotis Flevaris, Anna Chan, Xue Li, Scott A Diegel, Kathleen Wannemuehler, S...> ;JAMA Network Open. 2023 Oct 2
- Join now to see all
Abstracts/Posters
- Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDSAndrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...Andrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH InhibitorsAndrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Adult and Pediatric BMT61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete R...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- City of Hope Researchers Present Innovative Studies at American Society of Hematology (ASH) Annual MeetingDecember 13th, 2022
- City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021
- Sydnexis Raises $45M in Series B FundingAugust 11th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: